2019
DOI: 10.3390/antiox8030057
|View full text |Cite
|
Sign up to set email alerts
|

Gamma-Tocotrienol Protects the Intestine from Radiation Potentially by Accelerating Mesenchymal Immune Cell Recovery

Abstract: Natural antioxidant gamma-tocotrienol (GT3), a vitamin E family member, provides intestinal radiation protection. We seek to understand whether this protection is mediated via mucosal epithelial stem cells or sub-mucosal mesenchymal immune cells. Vehicle- or GT3-treated male CD2F1 mice were exposed to total body irradiation (TBI). Cell death was determined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Villus height and crypt depth were measured with computer-assisted software i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 13 publications
(22 citation statements)
references
References 43 publications
0
22
0
Order By: Relevance
“…Recent preclinical studies evidenced that GT3 may be a potential countermeasure against late degenerative tissue effects of high-LET radiation in the heart [ 190 ] and lung radiation injury [ 191 ]. Tocotrienols accumulate in the intestine to a greater level than tocopherols, and this can be involved in its greater ability to attenuate GIS [ 192 ]. γ-tocotrienols seem to have a greater efficacy as radioprotectors attributed [ 189 ] to their: (a) higher antioxidant potential [ 191 ], (b) capacity to downregulate proapoptotic/antiapoptotic ratio [ 193 ], (c) ability to accumulate in endothelial cells and intestinal epithelium which facilitates the recovery of mesenchymal immune cells [ 192 ], and (d) ability to inhibit HMG-CoA reductase, helping to avoid chronic inflammatory responses associated to radio-induced vascular and intestinal damage [ 185 ].…”
Section: Medical Countermeasuresmentioning
confidence: 99%
See 1 more Smart Citation
“…Recent preclinical studies evidenced that GT3 may be a potential countermeasure against late degenerative tissue effects of high-LET radiation in the heart [ 190 ] and lung radiation injury [ 191 ]. Tocotrienols accumulate in the intestine to a greater level than tocopherols, and this can be involved in its greater ability to attenuate GIS [ 192 ]. γ-tocotrienols seem to have a greater efficacy as radioprotectors attributed [ 189 ] to their: (a) higher antioxidant potential [ 191 ], (b) capacity to downregulate proapoptotic/antiapoptotic ratio [ 193 ], (c) ability to accumulate in endothelial cells and intestinal epithelium which facilitates the recovery of mesenchymal immune cells [ 192 ], and (d) ability to inhibit HMG-CoA reductase, helping to avoid chronic inflammatory responses associated to radio-induced vascular and intestinal damage [ 185 ].…”
Section: Medical Countermeasuresmentioning
confidence: 99%
“…Tocotrienols accumulate in the intestine to a greater level than tocopherols, and this can be involved in its greater ability to attenuate GIS [ 192 ]. γ-tocotrienols seem to have a greater efficacy as radioprotectors attributed [ 189 ] to their: (a) higher antioxidant potential [ 191 ], (b) capacity to downregulate proapoptotic/antiapoptotic ratio [ 193 ], (c) ability to accumulate in endothelial cells and intestinal epithelium which facilitates the recovery of mesenchymal immune cells [ 192 ], and (d) ability to inhibit HMG-CoA reductase, helping to avoid chronic inflammatory responses associated to radio-induced vascular and intestinal damage [ 185 ]. Moreover, recent studies have also evidenced the anti-cancer properties of γ-tocotrienols [ 179 ] and, although their low bioavailability is an important limiting factor [ 177 ], new formulations may help to overcome this pitfall.…”
Section: Medical Countermeasuresmentioning
confidence: 99%
“…We tested the efficacy of inhibitors of the mevalonate pathway, specifically, HMG-CoA reductase inhibitors (i.e., atorvastatin and GT3) and GGTi, in attenuating KLF2 suppression after fractionated radiation. We and others have shown HMG-CoA reductase inhibitors enhanced the expression of KLF2 and its downstream target molecules, such as TM and eNOS and provided radiation protection 28,30,38,39,41 . Treatment with atorvastatin, GT3, and GGTi significantly prevented fractionated radiation-induced suppression of not only KLF2 but also its downstream target molecules TM and eNOS (Fig.…”
Section: Mevalonate Pathway Inhibitors Prevent Fractionated Radiationmentioning
confidence: 83%
“…Appropriate positive and negative controls were included. Immunohistochemical staining for KLF2 and ICAM-1 was performed as described elsewhere 39 . Briefly, tissue sections were incubated with rabbit anti-KLF2 (1:100, LSBio, Seattle, WA, USA) or rabbit anti-ICAM-1 (1:250, Novus Biologicals, Centennial, CO, USA) antibodies for 2 hours.…”
mentioning
confidence: 99%
“…Intestinal epithelial cells exposed to radiation will lead to cell death due to oxidative stress, DNA fragmentation, apoptosis, etc., resulting in a radiation damage subsequent reaction [ 5 ]. The damage of epithelial cells not only affects the villus–crypt structural integrity, but also compromises the barrier integrity and enhances intestinal permeability, allowing enteric bacteria to invade the damaged tissue and cause intestinal inflammation [ 6 ].…”
Section: Introductionmentioning
confidence: 99%